Candel Therapeutics to Present at TD Cowen's 46th Annual Health Care Conference in Boston Life Science Investing
Annexon Biosciences to Present at the TD Cowen 46th Annual Health Care Conference Life Science Investing
Nautilus Biotechnology Unveils Voyager Platform, Enabling Single-Molecule Iterative Mapping, at US HUPO 2026 Life Science Investing
Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2025 Results Life Science Investing
Erasca Announces Issuance of a U.S. Patent Covering Pan-KRAS Inhibitor ERAS-4001 Life Science Investing
Helus Pharma Appoints Former Pfizer Chief Medical Officer Dr. Freda Lewis-Hall to Board of Directors & Chair of the Scientific Advisory Committee Medical Device Investing
Harmony Biosciences Reports Strong 2025 Financial Results and Reiterates 2026 Net Revenue Guidance of Over $1 Billion Life Science Investing
Beam Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Announces New Liver-Targeted Genetic Disease Program in Phenylketonuria Life Science Investing
Beam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth Street Life Science Investing
